James Gray, MD
Radiation Oncology · Nashville, TNNPI 1841219938
Payments from drug & device makers
Across 121 payments — averaging $393.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Progenics Pharmaceuticals, Inc.$31K
- Boston Scientific$3K
- Reflexion Medical, Inc.$3K
- Sanofi$3K
- Elekta, Inc.$2K
- Accuray Incorporated$2K
- plus $4K from 23 others
What the payments were for
- Consulting fees$2,5135%
- Speaking & faculty fees$28,84363%
- Travel & lodging$9,62121%
- Food & beverage$4,94111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Progenics Pharmaceuticals, Inc. | 35 | $31,248 |
| Boston Scientific | 22 | $3,075 |
| Reflexion Medical, Inc. | 9 | $2,698 |
| Sanofi | 3 | $2,614 |
| Elekta, Inc. | 2 | $2,345 |
| Accuray Incorporated | 3 | $1,921 |
| Palette Life Sciences, Inc. | 9 | $1,376 |
| Teleflex LLC | 7 | $1,103 |
| Blue Earth Diagnostics | 6 | $161 |
| Genentech USA, Inc. | 1 | $144 |
| GT Medical Technologies, Inc | 1 | $135 |
| Myovant Sciences Inc. | 1 | $120 |
| Profound Medical Corp. | 1 | $100 |
| AstraZeneca | 1 | $98 |
| Novocure Inc. | 2 | $95 |
| Bioprotect Medical, Inc. | 2 | $58 |
| Merck | 2 | $48 |
| Amgen | 2 | $43 |
| Amarin Pharma, Inc. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Isoray, Inc | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| AbbVie | 1 | $20 |
| Bristol Myers Squibb | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $19 |
| Johnson & Johnson | 1 | $15 |
| Novartis | 1 | $14 |
| Foundation Medicine, Inc. | 1 | $13 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PYLARIFY$31,024
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM$2,603
- JEVTANA$2,513
- SpaceOAR VUE System - 10mL$2,509
- ELEKTA MEDICAL LINEAR ACCELERATOR$2,345
- CyberKnife System$251
- TomoTherapy System$251
- GammaTile$135
- GENERAL - THERAPIES$124
- ORGOVYX$120
- GENERAL ONCOLOGY$108
- Barrigel$101
- Tulsa-Pro$100
How this compares
$47,588 in reported general payments places this provider in the 90th percentile of 115 radiation oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 107 | $1,547 |
| Oxybutynin Chloride | 13 | $233 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Nashville
- Evan OsmundsonNashville$727K
- Andrew KennedyNashville$251K
- Han-Chih ChangNashville$66K
- Karen WinkfieldNashville$53K
- Austin KirschnerNashville$52K
- Anuradha ChakravarthyNashville$37K
- John PhillipsNashville$23K
- Casey LipscombNashville$23K
- Anthony CmelakNashville$16K
- Joshua MondscheinNashville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.